Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 1419545, 11 pages
https://doi.org/10.1155/2017/1419545
Research Article

An Imaging and Histological Study on Intrahepatic Microvascular Passage of Contrast Materials in Rat Liver

1Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pu Jian Road, Shanghai 200127, China
2Department of Imaging and Pathology, University Hospitals, KU Leuven, Herestraat 49, 3000 Leuven, Belgium

Correspondence should be addressed to Yicheng Ni; eb.nevueluk@in.gnehciy

Received 2 October 2016; Accepted 15 January 2017; Published 15 February 2017

Academic Editor: Martin G. Mack

Copyright © 2017 Qian Xia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-M. Idée and B. Guiu, “Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review,” Critical Reviews in Oncology/Hematology, vol. 88, no. 3, pp. 530–549, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Wolff, “Physiology and pharmacology of iodized oil in goiter prophylaxis,” Medicine, vol. 80, no. 1, pp. 20–36, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. C.-M. Lo, H. Ngan, W.-K. Tso et al., “Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma,” Hepatology, vol. 35, no. 5, pp. 1164–1171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Llovet, M. I. Real, X. Montaña et al., “Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial,” The Lancet, vol. 359, no. 9319, pp. 1734–1739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. D. Ryder, P. M. Rizzi, E. Metivier, J. Karani, and R. Williams, “Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma,” Gut, vol. 38, no. 1, pp. 125–128, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Okada, “Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues,” Hepatology, vol. 27, no. 6, pp. 1743–1744, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Li, P.-H. Wu, J.-Q. Li, W.-Z. Zhang, H.-G. Lin, and Y.-Q. Zhang, “Segmental transcatheter arterial embolization for primary hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 4, no. 6, pp. 511–512, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Kan and D. C. Madoff, “Liver anatomy: microcirculation of the liver,” Seminars in Interventional Radiology, vol. 25, no. 2, pp. 77–85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Nakamura, T. Hashimoto, H. Oi, and S. Sawada, “Iodized oil in the portal vein after arterial embolization,” Radiology, vol. 167, no. 2, pp. 415–417, 1988. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Terada, F. Ishida, and Y. Nakanuma, “Vascular plexus around intrahepatic bile ducts in normal livers and portal hypertension,” Journal of Hepatology, vol. 8, no. 2, pp. 139–149, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. T. L. Kline, B. E. Knudsen, J. L. Anderson, A. J. Vercnocke, S. M. Jorgensen, and E. L. Ritman, “Anatomy of hepatic arteriolo-portal venular shunts evaluated by 3D micro-CT imaging,” Journal of Anatomy, vol. 224, no. 6, pp. 724–731, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Onori, E. Gaudio, A. Franchitto, G. Alpini, and H. Francis, “Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes,” World Journal of Gastrointestinal Pathophysiology, vol. 1, no. 2, pp. 38–49, 2010. View at Publisher · View at Google Scholar
  13. P. Ruemmele, F. Hofstaedter, and C. M. Gelbmann, “Secondary sclerosing cholangitis,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 5, pp. 287–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. J. Li, F. Chen, Y. B. Feng et al., “Diverse responses to vascular disrupting agent combretastatin A4 phosphate: a comparative study in rats with hepatic and subcutaneous tumor allografts using MRI biomarkers, microangiography, and histopathology,” Translational Oncology, vol. 6, no. 1, pp. 42–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Q. Xia, Y. Feng, T. Yin et al., “A multifunctional contrast dye for morphological research,” Microscopy Research and Technique, vol. 79, no. 2, pp. 111–121, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Feng, Z. L. Ma, F. Chen et al., “Bifunctional staining for ex vivo determination of area at risk in rabbits with reperfused myocardial infarction,” World Journal of Methodology, vol. 3, no. 3, pp. 27–38, 2013. View at Publisher · View at Google Scholar
  17. D. A. Levison, P. R. Crocker, A. Smith, A. J. Blackshaw, and C. I. Bartram, “Varied light and scanning electron microscopic appearances of barium sulphate in smears and histological sections,” Journal of Clinical Pathology, vol. 37, no. 5, pp. 481–487, 1984. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Lian, C.-K. Chui, and S.-H. Teoh, “A biomechanical model for real-time simulation of PMMA injection with haptics,” Computers in Biology and Medicine, vol. 38, no. 3, pp. 304–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. J. Cho and A. Lunderquist, “The peribiliary vascular plexus: the microvascular architecture of the bile duct in the rabbit and in clinical cases,” Radiology, vol. 147, no. 2, pp. 357–364, 1983. View at Publisher · View at Google Scholar · View at Scopus
  20. C. S. Ramesh Babu and M. Sharma, “Biliary tract anatomy and its relationship with venous drainage,” Journal of Clinical and Experimental Hepatology, vol. 4, supplement 1, pp. S18–S26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Richter, B. Vollmar, I. Mücke, S. Post, and M. D. Menger, “Hepatic arteriolo-portal venular shunting guarantees maintenance of nutritional microvascular supply in hepatic arterial buffer response of rat livers,” Journal of Physiology, vol. 531, no. 1, pp. 193–201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kobayashi, Y. Nakanuma, and O. Matsui, “Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey,” Human Pathology, vol. 25, no. 9, pp. 940–946, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. X. Kan, K. Ivancev, I. Hägerstrand, V. P. Chuang, and A. Lunderquist, “In vivo microscopy of the liver after injection of lipiodol into the hepatic artery and portal vein in the rat,” Acta Radiologica, vol. 30, no. 4, pp. 419–425, 1989. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Karssemeijer, J. T. M. Frieling, and J. H. C. L. Hendriks, “Spatial resolution in digital mammography,” Investigative Radiology, vol. 28, no. 5, pp. 413–419, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Collardeau-Frachon and J.-Y. Scoazec, “Vascular development and differentiation during human liver organogenesis,” Anatomical Record, vol. 291, no. 6, pp. 614–627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Varela, M. I. Real, M. Burrel et al., “Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics,” Journal of Hepatology, vol. 46, no. 3, pp. 474–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. H. Kim, M. S. Choi, Y. S. Choi et al., “Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma,” The Korean Journal of Hepatology, vol. 12, no. 1, pp. 55–64, 2006. View at Google Scholar · View at Scopus
  28. W. Lu, Y.-H. Li, Z.-J. Yu et al., “A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma,” Hepato-Gastroenterology, vol. 54, no. 77, pp. 1499–1502, 2007. View at Google Scholar · View at Scopus
  29. J. Xia, Z. Ren, S. Ye et al., “Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer,” European Journal of Radiology, vol. 59, no. 3, pp. 407–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Buijs, J. A. Vossen, C. Frangakis et al., “Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization—single-center experience,” Radiology, vol. 249, no. 1, pp. 346–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Monier, B. Guiu, R. Duran et al., “Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion,” European Radiology, pp. 1–9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Inoue, A. Hori, M. Satake et al., “Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS),” Nippon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica, vol. 52, no. 2, pp. 155–163, 1992. View at Google Scholar · View at Scopus